Literature DB >> 24756231

[Role of MRI for detection and characterization of pulmonary nodules].

G Sommer1, M Koenigkam-Santos, J Biederer, M Puderbach.   

Abstract

BACKGROUND: Due to physical and technical limitations, magnetic resonance imaging (MRI) has hitherto played only a minor role in image-based diagnostics of the lungs. However, as a consequence of important methodological developments during recent years, MRI has developed into a technically mature and clinically well-proven method for specific pulmonary questions. OBJECTIVES AND METHODS: The purpose of this article is to provide an overview on the currently available sequences and techniques for assessment of pulmonary nodules and analyzes the clinical significance according to the current literature. The main focus is on the detection of lung metastases, the detection of primary pulmonary malignancies in high-risk individuals and the differentiation between pulmonary nodules of benign and malignant character. RESULTS AND
CONCLUSION: The MRI technique has a sensitivity of approximately 80 % for detection of malignant pulmonary nodules compared to the reference standard low-dose computed tomography (CT) and is thus somewhat inferior to CT. Advantages of MRI on the other hand are a higher specificity in differentiating malignant and benign pulmonary nodules and the absence of ionizing radiation exposure. A systematic use of MRI as a primary tool for detection and characterization of pulmonary nodules is currently not recommended due to insufficient data. The diagnostic potential of MRI for early detection and staging of malignant pulmonary diseases, however, seems promising. Therefore, further evaluation of MRI as a secondary imaging modality in clinical trials is highly warranted.

Entities:  

Mesh:

Year:  2014        PMID: 24756231     DOI: 10.1007/s00117-013-2604-4

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  30 in total

1.  Detection and size of pulmonary lesions: how accurate is MRI? A prospective comparison of CT and MRI.

Authors:  Tobias Heye; Sebastian Ley; Claus Peter Heussel; Hendrik Dienemann; Hans-Ulrich Kauczor; Waldemar Hosch; Martin Libicher
Journal:  Acta Radiol       Date:  2012-01-27       Impact factor: 1.990

2.  Fast T1- and T2-weighted pulmonary MR-imaging in patients with bronchial carcinoma.

Authors:  M Both; J Schultze; M Reuter; B Bewig; R Hubner; I Bobis; R Noth; M Heller; J Biederer
Journal:  Eur J Radiol       Date:  2005-03       Impact factor: 3.528

3.  Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.

Authors:  Yoshiharu Ohno; Hisanobu Koyama; Daisuke Takenaka; Munenobu Nogami; Yoshimasa Maniwa; Yoshihiro Nishimura; Chiho Ohbayashi; Kazuro Sugimura
Journal:  J Magn Reson Imaging       Date:  2008-06       Impact factor: 4.813

4.  Quantitative and qualitative assessment of non-contrast-enhanced pulmonary MR imaging for management of pulmonary nodules in 161 subjects.

Authors:  Hisanobu Koyama; Yoshiharu Ohno; Atsushi Kono; Daisuke Takenaka; Yoshimasa Maniwa; Yoshihiro Nishimura; Chiho Ohbayashi; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2008-05-06       Impact factor: 5.315

5.  Identifying minimally acceptable interpretive performance criteria for screening mammography.

Authors:  Patricia A Carney; Edward A Sickles; Barbara S Monsees; Lawrence W Bassett; R James Brenner; Stephen A Feig; Robert A Smith; Robert D Rosenberg; T Andrew Bogart; Sally Browning; Jane W Barry; Mary M Kelly; Khai A Tran; Diana L Miglioretti
Journal:  Radiology       Date:  2010-05       Impact factor: 11.105

6.  Lung nodule detection in a high-risk population: comparison of magnetic resonance imaging and low-dose computed tomography.

Authors:  Gregor Sommer; Jan Tremper; Marcel Koenigkam-Santos; Stefan Delorme; Nikolaus Becker; Jürgen Biederer; Hans-Ulrich Kauczor; Claus Peter Heussel; Heinz-Peter Schlemmer; Michael Puderbach
Journal:  Eur J Radiol       Date:  2013-12-04       Impact factor: 3.528

7.  Usefulness of diffusion-weighted MR imaging in the evaluation of pulmonary lesions.

Authors:  Haidong Liu; Ying Liu; Tielian Yu; Ning Ye
Journal:  Eur Radiol       Date:  2009-10-28       Impact factor: 5.315

8.  Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer.

Authors:  David J Brenner
Journal:  Radiology       Date:  2004-05       Impact factor: 11.105

9.  Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI?

Authors:  Shiro Satoh; Yoshio Kitazume; Shinichi Ohdama; Yuji Kimula; Shinichi Taura; Yasuyuki Endo
Journal:  AJR Am J Roentgenol       Date:  2008-08       Impact factor: 3.959

10.  MRI of the lung (2/3). Why … when … how?

Authors:  J Biederer; M Beer; W Hirsch; J Wild; M Fabel; M Puderbach; E J R Van Beek
Journal:  Insights Imaging       Date:  2012-02-13
View more
  3 in total

1.  [MRI of interstitial lung diseases: what is possible?].

Authors:  J Biederer; M O Wielpütz; B J Jobst; J Dinkel
Journal:  Radiologe       Date:  2014-12       Impact factor: 0.635

2.  Speeding up PET/MR for cancer staging of children and young adults.

Authors:  Maryam Aghighi; Laura Jean Pisani; Ziyan Sun; Christopher Klenk; Himani Madnawat; Sandra Luna Fineman; Ranjana Advani; Rie Von Eyben; Daniel Owen; Andrew Quon; Michael Moseley; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2016-04-05       Impact factor: 5.315

3.  Free-breathing 3D Stack of Stars GRE (StarVIBE) sequence for detecting pulmonary nodules in 18F-FDG PET/MRI.

Authors:  Nils Martin Bruckmann; Julian Kirchner; Janna Morawitz; Lale Umutlu; Wolfgang P Fendler; Ken Herrmann; Ann-Kathrin Bittner; Oliver Hoffmann; Tanja Fehm; Maike E Lindemann; Christian Buchbender; Gerald Antoch; Lino M Sawicki
Journal:  EJNMMI Phys       Date:  2022-02-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.